Daxor Cash on Hand 2010-2011 | DXR

Daxor cash on hand from 2010 to 2011. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Daxor Annual Cash on Hand
(Millions of US $)
2011 $56
2010 $54
2009 $54
Daxor Quarterly Cash on Hand
(Millions of US $)
2011-12-31 $56
2011-09-30 $52
2011-06-30 $54
2011-03-31 $53
2010-12-31 $54
2010-09-30 $58
2010-06-30 $49
2010-03-31 $76
2009-12-31 $54
2009-09-30 $70
2009-06-30 $70
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.053B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.011B 19.12
Encompass Health (EHC) United States $12.109B 24.19
DaVita (DVA) United States $9.527B 13.62
Elanco Animal Health (ELAN) United States $8.794B 19.67
Chemed (CHE) United States $6.482B 21.71
RadNet (RDNT) United States $5.099B 184.14
Option Care Health (OPCH) United States $4.575B 19.58
LifeStance Health (LFST) United States $2.104B 0.00
Addus HomeCare (ADUS) United States $2.102B 22.66
Astrana Health (ASTH) United States $1.678B 58.71
Aveanna Healthcare Holdings (AVAH) United States $1.471B 27.08
U.S Physical Therapy (USPH) United States $1.281B 32.04
Atai Life Sciences (ATAI) Germany $0.868B 0.00
Pennant (PNTG) United States $0.868B 30.62
MEDIROM Healthcare Technologies (MRM) Japan $0.054B 0.00
Psychemedics (PMD) United States $0.000B 0.00